Gain full access to the latest clinical content available from Springer Nature
Breaking headlines, in-depth features, hot topic review articles, and
the latest from major international conferences brought to you by
12-09-2017 | Breast cancer | ESMO 2017 | News
First-line abemaciclib supported for HR+HER2– advanced breast cancer
Results from the MONARCH 3 study give support to first-line use of the oral selective CDK4/6 inhibitor abemaciclib, taken alongside nonsteroidal aromatase inhibitor therapy, in patients with advanced hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer.
Ask the expert
Are you a healthcare professional with questions about the management of oncology patients? Submit a question here and we'll put a selection of the best to our advisory board.
10-09-2017 | Collection
We provide the latest research news, interviews, and much more from the ESMO 2017 Congress, in Madrid, Spain.
04-06-2017 | Collection
We provide coverage from the annual meeting of the American Society of Clinical Oncology, held in Chicago, Illinois, USA. Click through for news stories, conference reports, interviews and more.
03-02-2017 | Collection
News from annual meeting of the American Society of Hematology, held in San Diego, California, USA. Click through to read the full reports.
Neuer Inhalt, 3D breast cancer/© Sebastian Kaulitzki - Fotolia, Anas Younes, Lesley Fallowfield & Ethan Basch, Question mark, Calendar, Olivier Michielin, Floriana Morgillo, Suresh Ramalingam, Virginie Westeel, lung_cancer, 3D breast cancer/© Sebastian Kaulitzki - Fotolia, Lung cancer highlights image, white_pills_tablets, STAMPEDE image, LATITUDE image, Young girl_bandana/© Frantab / Fotolia, white_pills_tablets, David Hyman/© Shreeya Nanda